Discovery of <scp>CECR2</scp> Bromodomain Inhibitors with High Selectivities over <scp>BPTF</scp> Bromodomain-Reference-Cited by-同舟云学术

Discovery of CECR2 Bromodomain Inhibitors with High Selectivities over BPTF Bromodomain

Published:2022-06-21 Issue: Volume: Page:
ISSN:1001-604X
Container-title:Chinese Journal of Chemistry
language:en
Short-container-title:Chin. J. Chem.

Author:

Lu Haibo¹²,Zu Shijia²³,Duan Zhe⁴,Feng Yueyao⁵,Wang Jie⁵,Ma Jingyi³⁶,Li Qi²,Chen Dongying³⁶,Li Bo²,Chen Kaixian¹²³,Luo Cheng¹²³,Lin Jin⁷,Lu Tian⁸,Lin Hua⁵²

Affiliation:

1. School of Pharmacy, Fudan University 826 Zhangheng Road Shanghai 201203 China

2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zuchongzhi Road Shanghai 201203 China

3. University of Chinese Academy of Sciences 19 Yuquan Road Beijing 100049 China

4. School of Pharmacy, Nanchang University Nanchang Jiangxi 330006 China

5. Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University Fuzhou Fujian 350117 China

6. Laboratory of Pharmaceutical Analysis, Shanghai Institute of Materia Medica, Chinese Academy of Sciences 555 Zuchongzhi Road, Zhangjiang Hi‐Tech Park Shanghai 201203 China

7. School of Pharmacy, Fujian Medical University Fuzhou Fujian 350122 China

8. Guizhou University of Traditional Chinese Medicine Guiyang Guizhou 550025 China

Publisher

Wiley

Subject

General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjoc.202200208

Reference28 articles.

1. Bromodomain: an acetyl‐lysine binding domain;Zeng L.;FEBS Lett.,2002

2. BET inhibitors: a novel epigenetic approach;Doroshow D. B.;Ann. Oncol.,2017

3. Selective inhibition of BET bromodomains;Filippakopoulos P.;Nature,2010

4. Inhibition of BET Recruitment to Chromatin As An Effective Treatment for MLL‐Fusion Leukaemia;Dawson M. A.;Blood,2011

5. Therapeutic targeting of BET bromodomain proteins in castration‐resistant prostate cancer;Asangani I. A.;Nature,2014